Reva brings bioresorbable scaffolds to new markets

This article was originally published here

Reva MedicalReva Medical (ASX:RVA) said this week that it inked four new distribution agreements, bringing its commercial operations to seven European countries.

The San Diego, Calif.-based company said the deals serve to expand the reach of its drug-eluting bioresorbable scaffold, Fantom Encore.

Get the full story at our sister site, Drug Delivery Business News.

The post Reva brings bioresorbable scaffolds to new markets appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply